Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia

Vaccine

Volumn 31, Issue S7, 2013, Pages H46-

  Rogovskaya, Svetlana I ^a   Shabalova, Irina P ^a   Mikheeva, Irina V ^b   Minkina, Galina N ^c   Podzolkova, Nataly M ^a   Shipulina, Olga Y ^d   Sultanov, Said N ^e   Kosenko, Iren A ^f   Brotons, Maria ^g   Buttmann, Nina ^h   Dartell, Myassa ⁱ   Arbyn, Marc ^j,k   Syrjänen, Stina ^l   Poljak, Mario ^m  

^a Russian Medical Academy of Postgraduate Education   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Moscow Industrial University   (Russian Federation)

^d Central Institute of Epidemiology   (Russian Federation)

^e Ministry of Health Uzbekistan   (Uzbekistan)

^f Ministry of Health Republic of Belarus   (Belarus)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^h ROBERT KOCH INSTITUTE   (Germany)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^k UNIVERSITY OF ANTWERP   (Belgium)

^l UNIVERSITY OF TURKU   (Finland)

^m UNIVERSITY OF LJUBLJANA   (Slovenia)

more..

Author keywords

Caucasus region; Central Asia; Cervical cancer; Eastern Europe; HPV; HPV vaccination; Screening

Indexed keywords

WART VIRUS VACCINE;

ASIA; CANCER SCREENING; COLPOSCOPY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RUSSIAN FEDERATION; SYSTEMATIC REVIEW; USSR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; WESTERN EUROPE;

EID: 84890192684     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.043     Document Type: Review

References (55)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19.
2. Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009, 384:260-265.
3. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370(9590):890-907.
4. Shevchenko E.A., Uspenskaia O.A. [Clinical, epidemiological, and pathogenetic aspects of formation of persisting forms of high oncogenic risk papillomavirus infection in women]. Zh Mikrobiol Epidemiol Immunobiol 2009, 2:101-103. Russian.
5. Crochard A., Luyts D., di Nicola S., Gonçalves M.A. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol 2009, 115(Suppl 3):S7-S14.
6. Belaya Y., Zarochenceva NM. [Papillomavirus infection in Moscow Region adolescent girls]. [Reproductive health of children and adolescents] 2011;5:14-8. Russian.
7. Saveleva IS, Volkova OI, Gorodnicheva ZHA. [Reproductive behavior and reproductive health in terms of teenagers: requirements and needs]. [Reproductive health of children and adolescents] 2006;(Suppl. 4):23-33. Russian.
8. Syrjänen K., Shabalova I., Naud P., Derchain S., Sarian L., Kozachenko V., et al. so-factors of high-risk human papillomavirus infection display unique profiles in incident CIN1, CIN2 and CIN3. Analysis of the combined prospective cohort of the NIS and LAMS Studies. Int J STD AIDS 2011, 22:263-272.
9. Bray F., Lortet-Tieulent J., Znaor A., Brotons M., Poljak M., Arbyn M. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H32-H45.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr (last accessed May 2013).
11. Poljak M., Seme K., Maver P.J., Kocjan B.J., Cuschieri K.S., Rogovskaya S.I., et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe. Vaccine 2013, 31S:H59-H70.
12. Kuevda D, Trofimova O, Bolshenko N. [High-risk HPV prevalence and HPV-associated pathology among dermatovenereological patients]. [Infectious Diseases] 2009;4:28-32. Russian.
13. Kulmala S.M., Shabalova I.P., Petrovitchev N., Syrjänen K.J., Gyllensten U.B., Syrjänen S.M., et al. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol 2007, 79:771-781.
14. Alibegashvili T., Clifford G.M., Vaccarella S., Baidoshvili A., Gogiashvili L., Tsagareli Z., et al. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol 2011, 35:465-470.
15. Buleshov M.A., Nartaeva M.M., Tleujan R.T., Kullbaeva S.N., Kazyibaeva Z.A. [The prophylaxis of premalignant diseases and tumours of reproductive system women organs in the South Kazakhstan region (SKR)]. Astrakhan Medical Journal 2011, 6(1). 166-8. Russian.
16. Kubanov A.A. [Results of HPV genotyping during screening research in Moscow region]. The Bulletin of Dermatology and Venereology 2005, (Suppl 1):51-55. Russian.
17. Komarova E.V., Minkina G.N., Gavrikova M.V. [HPV: Human papilloma virus - testing and genotyping in cervical neoplasia diagnostics]. J Medicine of Critical Conditions 2010, (Suppl 1):54-61.
18. Bdaizieva E.T., Mikheyeva I.V. [Estimation of HPV prevalence]. Preventive medicine to practical public health services. Conference of the Faculty of Preventive Medicine, I. M. Sechenov Moscow Medical Academy 2010, (Suppl 4):193-198. Russian.
19. Shipulina O., Mikheeva I., Romaniuk T., Belaya Yu, Zarochenceva N. [The incidence of STD and high- and low-risk HPV in adolescent girls in Moscow Region]. Epidemiology and Vaccine Prophilaxic 2011, 6:35-41. Russian.
20. Shargorodskaya A., Shipulina O., Romaniuk T., Leshkina G., Martyanova V., Rogovskaya S., et al. [The particuliarity of HPV transmission]. [Mother and Child in Kuzbass] 2011, 1:335-338. Russian.
21. Goncharevskaya Z, Shipulina O, Mikheeva I, Rogovskaya S, Romanyuk T, Shipulin G, et al. [The use of HPV testing in cervical screening]. Proceedings of the XII All-Russian Congress Mother and Child; 2011 Sep 27-30; Moscow, Russia. Abstract in Russian.
22. Alexandrova Y.N., Lyshchov A.A., Safronnikova N.R., Imyanitov E.N., Hanson K.P. Features of HPV infection among the healthy attendants of gynecological practice in St. Petersburg, Russia. Cancer Lett 1999, 145(1-2):43-48.
23. Shipitsyna E., Zolotoverkhaya E., Kuevda D., Nasonova V., Romanyuk T., Khachaturyan A., et al. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer Epidemiol 2011, 35:160-164.
24. Evstigneeva N.P. [Molecular genotyping of HPV in Ural region]. [Current issues of dermatology, immunology and clinical cosmetology] s 2009, 4:24. Russian.
25. Inamova S.T., Sultanov S.N., Aripjanova D.S. [Rate and prevalence of SIL among women with papillomavirus infection]. [News of dermatology and reproductive health] 2009, 4:39. Russian.
26. Kulmala S.M., Syrjänen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J., et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004, 42(6):2470-2475.
27. Korolenkova L.I., Bryuzgin V.V., Korolenkova L., Bryuzgin V. [Severe cervical intraepithelial neoplasias (CINII-III/carcinoma in situ) and microcarcinoma of the cervix in pregnant women]. Obstetrics and Gynecology 2011, 5:68-73. Russian.
28. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., Schegget J., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999, 37(8):2508-2517.
29. Zumbach K., Kisseljov F., Sacharova O., Shaichaev G., Semjonova L., Pavlova L., et al. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Int J Cancer 2000, 85(3):313-318.
30. Zolotoverkhaya E., Shipitsyna E., Yushmanova Ye. [Oncogenic types of papillomavirus in women with cervical pathology]. [Journal of Obstetrics and Gynecological Disorders] 2009, 8:83-89. Russian.
31. Samoylova E.V., Shaikhaiev G.O., Petrov S.V., Kisseljova N.P., Kisseljov F.L. HPV infection in cervical-cancer cases in Russia. Int J Cancer 1995, 61(3):337-341.
32. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjosé S., Franceschi S., et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131(10):2349-2359.
33. Shabalova I.P., Dzhangirova T.V., Kasojan K.T. [New technologies for the training in cytological diagnostics.]. The Manual of the manager of clinical and diagnostic laboratory 2010, (Suppl 7):32-36. Russian.
34. Kairbayev M, Chingisova Z, Shibanova A, Shalbayeva R, Belamanova L, Kukubassov E. The first experience of cytology based cervical cancer screening in Kazakhstan: problems and first results. [Conference abstract, ESGO 2009] Int J Gynecol Cancer 2009; 19(Suppl. 2):571.
35. Polykov S, Levin L, Shebeko N, Scherbina O. Malignant neoplasms in Belarus in 2000-2009, 2010, RNPC MT, Minsk, Belarus. Russian.
36. Katsaga A., Kulzhanov M., Karanikolos M., Rechel B. Kazakhstan: Health system review. Health Systems in Transition. 2012, 14(4):1-154.
37. Novik V.I. [Screening of cervical cancer]. [Practical Oncology] 2010, (Suppl 2):66-73. Russian.
38. Sarian L.O., Derchain S., Shabalova I., Tatti S., Naud P., Longatto-Filho A., et al. Optional screening strategies for cervical cancer using stand alone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe. J Med Screen 2010, 17:195-203.
39. Chissov VI, Starinsky VV, Petrova GV. [Oncology in Russia in 2010: Morbidity and mortality]. Guidelines of Herzen Oncology Institute, Moscow 2011, p. 188. Russian.
40. Sdvizkov AM, Vasilieva ID, Evtyagin VV, Kropacheva TD. [Moscow cytological screening]. The XIVth Russian Oncology Congress, Moscow 2011. Russian.
41. Tatarchuk TF, Kalugina LV, Regeda S. [Cervical pathology in women-adolescents infected by HPV]. J Women's Health. Kiev, Ukraine, No.8 (44) 2009 P.132. Ukrainian.
42. Vorobieva L.I. [Cervical cancer: improvement in diagnostics and treatment]. [Health of Ukraine] 2009, 1:15. Russian.
43. Beljakovsky V.N., Voropajev E.V., Volchenko A.N., Prigozaya T.I., Stasenkova S.V., Grebenyak B.I., et al. [Epidemiologic features of genital HPV infection in healthy women of the Gomel area.]. [Problems of Health and Ecology] 2010, 23(Suppl 3):78-83. Russian.
44. Vergejchik G.I., Eremin V.F. [Molecular-genetic features of HR papillomavirus circulating in the Republic of Belarus]. [Medical News] m2011, (Suppl 8):76-80. Belorussian.
45. Kostevich G.V., Kosenko I.A. [Results of HPV diagnostics in cervical pathology in Belarus]. [Journal of Oncology] O2010, 4:33-36. Russian.
46. Digol I. [Risk factors for infection of uterine cervix with human papillomavirus oncogene types]. PhD thesis. Kishinev, Moldova 2005. Russian. Available at: (last accessed May 2013). http://www.cnaa.md/en/thesis/3527/.
47. Maglakelidze M. Summary Report on Screening Programmes in Black Sea Countries (BSC) Member Countries. Second meeting of the BSC Coalition Steering Committee, Istanbul Turkey, 2011. Russian. Available at: (last accessed May 2013). http://www.bsc-coalition.com/%3Fd1=content%26id=82.
48. National Strategy, Programme and Actions Time Framework on Reproductive Health Improvement 2007-2015. 2007; Yerevan, Armenia.
49. Barnekow V. Policy development in Kazakhstan. Entre Nous - The European Magazine for Sexual and Reproductive Health 2011, 74:5.
50. Izmaylova ZM. [Epidemological and prophylactic aspects of cervical cancer in the Republic of Kyrgyzstan]. PhD thesis. Bishkek 2005. Russian. Available at: (last accessed May 2013). http://www.dissercat.com/content/epidemiologicheskie-aspekty-i-voprosy-profilaktiki-raka-sheiki-matki-v-kyrgyzskoi-respublike.
51. Umarova S.G., Karimov F.N., Zikirjahodzhaev D.Z. [Some epidemiological aspects of cancer of the reproductive system of women in Tajikistan]. Siberian Journal of Oncology 2009, (Suppl 2):192-193. Russian.
52. Uzbekan Ministry of Health Order No. 312.
53. [Cervical cancer prevention Guidelines]. Edited by Sukhikh G. and Prilepskaya V., 2012, Medpress, Moscow. Russian.
54. Zur Hausen H. HPV vaccines: what remains to be done? Interview by Lauren Constable. Expert Rev Vaccines 2011, 10(11):1505-1507.
55. Poljak M., Rogovskaya S.I., Kesić V., Bray F., Berkhof J., Seme K., et al. Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H80-H82.